慢性乙型肝炎患者血清HBeAg水平对阿德福韦酯抗病毒疗效的影响

doi:10.3969/j.issn.1672-5069.2015.04.020

Abstract

Ding Junqi，Yao Jianhua，Ma Chenbin，et al.. Impact of serum HBeAg levels on response of patients with chronic hepatitis B receiving adefovir dipivoxil therapy[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(4): 409-410.

References

[1] 徐铭益，张启迪，李郑红，等.慢性乙型肝炎肝纤维化患者肝组织基因表达谱和功能分类.肝脏，2013，18（7）:435-438.
[2] 魏来，杨瑞峰.乙型肝炎病毒e抗原定量检测的发展和意义. 中华肝脏病杂志，2011，19（11）:806.
[3] 占国清，谭华炳，李儒贵，等.替比夫定与阿德福韦酯治疗HBeAg阳性慢性乙型肝炎的疗效观察. 实用肝脏病杂志，2011，14（1）:23-24，49.
[4] 沙小莹，王宏利，郭雅玲，等. 慢性乙型肝炎病毒 e 抗原水平对抗病毒疗效的影响. 实用临床医药杂志，2014，18（15）:148-149.
[5] 中华医学会肝病学分会和感染病学分会.慢性乙型肝炎防治指南（2010年版）. 实用肝脏病杂志，2011，14（2）：81-89.
[6] 王薇，孙公凯，杨世忠. 慢性乙型肝炎的现代研究进展. 海南医学院学报，2011，17（6）:861.
[7] 阮炳威，陈荣策，曾广忠，等. 基线ALT水平对阿德福韦酯治疗H BeAg阳性慢性乙型肝炎疗效的影响. 肝脏，2013，18（2）:94-96.
[8] 陈文平. 聚乙二醇干扰素与拉米夫定治疗 HBeAg 阳性慢性乙型肝炎疗效比较. 海南医学院学报，2011，17（9）:1189.
[9] 林明华，高海兵，潘晨，等.阿德福韦酯治疗HBeAg阳性慢性乙型肝炎病毒学应答的预测因素分析. 中华传染病杂志，2011，29（11）:468-473.
[10] Zeuzem S，Gane E，Liaw YF，et a1.Baseline characteristics and early on-treatment response predict the outcomes of 2 years of telbivudine treatment of chronic hepatitis B. J Hepatol，2009，51（1）:11-20.
[11] 钮志林，高胜利，俞净，等. 阿德福韦酯治疗慢性乙型肝炎患者的疗效观察. 实用肝脏病杂志，2010，13（1）:345-346.
[12] 淑珍，徐启恒. 乙型肝炎肝硬化抗病毒治疗48周的临床疗效.中华传染病杂志，2010，28（11）:164-167.
[13] 戎云清.阿德福韦酯和拉米夫定治疗慢性乙型肝炎疗效对比观察. 实用肝脏病杂志，2012，15（2）:137-139.

[1]	chronic hepatitis B Zhu Lingyun, Zhang Maohai Cui Shasha, et al.. Serum IL-12 and IL-18 levels as well as peripheral blood mononuclear cell FOXp3 in patients with [J]. Journal of Practical Hepatology, 2019, 22(6): 816-819.
[2]	Shi Yingying, Wang Yuanxi.. Impact of combination telbivudine and adefovir dipivoxil on renal functions in the treatment of patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(6): 820-823.
[3]	patients with chronic hepatitis B Zhang Yingming, Shen Shuang, Tian Fei, et al.. Prediction of response to peginterferon alfa-2a by blood IFNL4 and IL-28B gene polymorphisms in [J]. Journal of Practical Hepatology, 2019, 22(6): 828-831.
[4]	Zhu Yage, Liu Jinfeng.. Therapeutic efficacy of adenosine methionine and glycyrrhizin combination in treatment of patients with alcoholic cirrhosis and its effect on serum BGP levels [J]. Journal of Practical Hepatology, 2019, 22(6): 872-875.
[5]	Zhao Xieshan, Wu Chunrong, Wang Chunfeng, et al. Preliminary study on the efficacy of combination of tenofovir and Anluo Huaxian pill in the treatment of patients with HBeAg-negative chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 644-647.
[6]	Gao Wei, Hou Yong. Diagnostic efficacy of hepatic fibrosis by liver stiffness measurement in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 652-655.
[7]	Zhao Fangfang, Zhai Yongzhen, Feng Guohe. Efficacy and safety of autologous peripheral blood stem cell transplantation in patients with hepatitis B cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 700-703.
[8]	Zhang Zhicheng, Yuan Guangqi, Mo Chanjun. Impact of blood supply on efficacy of hepatic artery embolization in treatment of patients with hepatic hemangioma [J]. Journal of Practical Hepatology, 2019, 22(5): 736-739.
[9]	Bai Yichun, Deng Jihong, Mei Xiaoping. Efficacy of peginterferon alfa-2b treatment and affecting response factors in patients with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 490-493.
[10]	Zhang Yafei, Ye Jun, Xie Qinxiu, et al. Difference in predicting efficacy of significant liver fibrosis by noninvasive liver fibrosis index in different hospitals [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 510-513.
[11]	Yan Lingling, Hu Donghui, Huang Yanfang. Influence of ademetionine combined with polyene phosphatidylcholine on clinical efficacy and laboratory index in patients with intrahepatic cholestasis of pregnancy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 530-533.
[12]	Wang Baodan, Li Meng, Gao Yu. Predictive factors of response to interferon-α antiviral therapy in children with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 345-348.
[13]	Yuan Chunhui, Li Chunyu, Li Hongli. Efficacy of pegylated interferon α -2b in the treatment of patients with serum HBeAg positive chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 353-356.
[14]	Ma Xiaosu, Pei Renming Zhang Tingting. Comparison of magnetic resonance cholangiopancreatography with color Doppler ultrasound in diagnosis of patients with common bile duct stones [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 433-436.
[15]	Yuan Chunhui, Li Chunyu, Li Hongli, Zhao Hongna, Wen Wenhong, Meng Qingxu, Zhang Zhongxue. Impact of blood IL28B gene polymorphism on viralogic response in patients with HBeAg positive chronic hepatitis B receiving peginterferon alfa therapy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 184-187.

Impact of serum HBeAg levels on response of patients with chronic hepatitis B receiving adefovir dipivoxil therapy

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments